ARCHIVES

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science

October 28, 1994

NCI funds four radiation oncology cancer disparities research partnerships.

October 10, 2003

NCI to Host SBIR Investor Forum

November 7, 2014

Without Advance Directives, Families Prolong Treatment

April 27, 2001

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979